SCHEMBL5689684

SCHEMBL5689684

Oc1ccc(C2CCC(NCCC(O)c3ccccc3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.45
SOS1 Q07889 1/20 0.45
MPO P05164 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ESR2 Q92731 3/20 0.41
ESR1 P03372 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689681 1.00 GRIN2B (0.45) GRIN2BSOS1MPOKDM4EALDH1A1
SCHEMBL5691602 0.85 SOS1 (0.43) SOS1MPOALDH1A1SMN1; SMN2ESR2
SCHEMBL5691598 0.85 SOS1 (0.43) SOS1MPOALDH1A1SMN1; SMN2ESR2
SCHEMBL5690064 0.85 KDM4E (0.49) GRIN2BKDM4ESMN1; SMN2CYP2C9GRIN1
SCHEMBL5690073 0.85 KDM4E (0.49) GRIN2BKDM4ESMN1; SMN2CYP2C9GRIN1
SCHEMBL5690067 0.85 KDM4E (0.49) GRIN2BKDM4ESMN1; SMN2CYP2C9GRIN1
SCHEMBL5689744 0.78 GRIN2B (0.55) GRIN2B
SCHEMBL5691767 0.78 GRIN2B (0.55) GRIN2B
SCHEMBL5689748 0.78 GRIN2B (0.55) GRIN2B
SCHEMBL7055707 0.77 KDM4E (0.62) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 EP disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed